Matthew J Renwick

789 total citations
13 papers, 518 citations indexed

About

Matthew J Renwick is a scholar working on Economics and Econometrics, Immunology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Matthew J Renwick has authored 13 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Economics and Econometrics, 6 papers in Immunology and 3 papers in Applied Microbiology and Biotechnology. Recurrent topics in Matthew J Renwick's work include Pharmaceutical Economics and Policy (7 papers), Biosimilars and Bioanalytical Methods (6 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Matthew J Renwick is often cited by papers focused on Pharmaceutical Economics and Policy (7 papers), Biosimilars and Bioanalytical Methods (6 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Matthew J Renwick collaborates with scholars based in United Kingdom, United States and Canada. Matthew J Renwick's co-authors include Elías Mossialos, David M. Brogan, Victoria L. Simpkin, Deirdre Weymann, Kate Smolina, Emilie J. Gladstone, Steven G. Morgan, Ashish K. Jha, Jamie A. Cohen and Alex Mezei and has published in prestigious journals such as The Lancet Oncology, Social Science & Medicine and Journal of the American Heart Association.

In The Last Decade

Matthew J Renwick

12 papers receiving 501 citations

Peers

Matthew J Renwick

AMB

IMMUN

Christine Årdal Norway

Barbara Milani Switzerland

Abdol Majid Cheraghali Iran

Kah Seng Lee Malaysia

K. Hemalatha Ethiopia

Seamus O’Brien United Kingdom

Dan N. Tran United States

Aylin Sertkaya United States

Victoria L. Simpkin United Kingdom

Carlos A. Rodríguez Colombia

Christine Årdal Norway

Matthew J Renwick

246 ×1.5

251 ×2.7

AMB

166 ×1.8

192 ×2.4

77 ×1.0

IMMUN

Citations per year, relative to Matthew J Renwick Matthew J Renwick (= 1×) peers Christine Årdal

Countries citing papers authored by Matthew J Renwick

Since Specialization

Citations

This map shows the geographic impact of Matthew J Renwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J Renwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J Renwick more than expected).

Fields of papers citing papers by Matthew J Renwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J Renwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J Renwick. The network helps show where Matthew J Renwick may publish in the future.

Co-authorship network of co-authors of Matthew J Renwick

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J Renwick. A scholar is included among the top collaborators of Matthew J Renwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J Renwick. Matthew J Renwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Renwick, Matthew J, et al.. (2024). Management of phthalates in Canada and beyond: can we do better to protect human health?. Frontiers in Public Health. 12. 1473222–1473222. 4 indexed citations

Mezei, Alex, Jamie A. Cohen, Matthew J Renwick, Jessica E. Atwell, & Allison Portnoy. (2021). Mathematical modelling of respiratory syncytial virus (RSV) in low- and middle-income countries: A systematic review. Epidemics. 35. 100444–100444. 15 indexed citations

Renwick, Matthew J, et al.. (2020). Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England. EClinicalMedicine. 29-30. 100625–100625. 31 indexed citations

Renwick, Matthew J, et al.. (2020). Cost‐Effectiveness of Cardiovascular, Obesity, and Diabetes Mellitus Drugs: Comparative Analysis of the United States and England. Journal of the American Heart Association. 9(21). e018281–e018281. 1 indexed citations

Renwick, Matthew J & Elías Mossialos. (2020). Fostering R&D of novel antibiotics and other technologies to prevent and treat infection. European Journal of Public Health. 30(Supplement_5). 1 indexed citations

Simpkin, Victoria L., et al.. (2017). Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps. The Journal of Antibiotics. 70(12). 1087–1096. 162 indexed citations

Simpkin, Victoria L., et al.. (2017). Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps. London School of Economics and Political Science Research Online (London School of Economics and Political Science).

Renwick, Matthew J & Elías Mossialos. (2017). Crowdfunding our health: Economic risks and benefits. Social Science & Medicine. 191. 48–56. 76 indexed citations

Román-Urrestarazu, Andrés, et al.. (2016). Structural equation model for estimating risk factors in type 2 diabetes mellitus in a Middle Eastern setting: evidence from the STEPS Qatar. BMJ Open Diabetes Research & Care. 4(1). e000231–e000231. 12 indexed citations

10.

Renwick, Matthew J, Victoria L. Simpkin, & Elías Mossialos. (2016). Targeting innovation in antibiotic drug discovery and development. 12 indexed citations

11.

Renwick, Matthew J, Kate Smolina, Emilie J. Gladstone, Deirdre Weymann, & Steven G. Morgan. (2015). Postmarket policy considerations for biosimilar oncology drugs. The Lancet Oncology. 17(1). e31–e38. 49 indexed citations

12.

Renwick, Matthew J, David M. Brogan, & Elías Mossialos. (2015). A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics. The Journal of Antibiotics. 69(2). 73–88. 147 indexed citations

13.

Renwick, Matthew J, et al.. (1992). Long-stay older patients in acute hospitals: are they bed blockers?. PubMed. 15(3). 284–98. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact